Kangyu Chen

404 total citations
30 papers, 233 citations indexed

About

Kangyu Chen is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Kangyu Chen has authored 30 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cardiology and Cardiovascular Medicine, 7 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Surgery. Recurrent topics in Kangyu Chen's work include Blood Pressure and Hypertension Studies (9 papers), Cardiac pacing and defibrillation studies (6 papers) and Cardiovascular Function and Risk Factors (6 papers). Kangyu Chen is often cited by papers focused on Blood Pressure and Hypertension Studies (9 papers), Cardiac pacing and defibrillation studies (6 papers) and Cardiovascular Function and Risk Factors (6 papers). Kangyu Chen collaborates with scholars based in China, United Kingdom and New Zealand. Kangyu Chen's co-authors include Hongqi Li, Yan Ji, Hao Su, Weiliang Shen, Zhenqiang Wu, Hao Su, Tao Chen, Victoria Cornelius, Qi Wang and Chao Li and has published in prestigious journals such as Scientific Reports, Journal of Business Research and PLoS Medicine.

In The Last Decade

Kangyu Chen

23 papers receiving 229 citations

Peers

Kangyu Chen
Chandrashekhar K. Ponde India
Anna Di Lorenzo Italy
Xinchun Yang China
Alessandra M. Campos‐Staffico Brazil
Cinzia Nugara Italy
Matthew R. Deshotels United States
Hani Sabbour United Arab Emirates
Vincenzo Sucato Italy
I Sathyamurthy India
Tariq Ali Ahmad United States
Chandrashekhar K. Ponde India
Kangyu Chen
Citations per year, relative to Kangyu Chen Kangyu Chen (= 1×) peers Chandrashekhar K. Ponde

Countries citing papers authored by Kangyu Chen

Since Specialization
Citations

This map shows the geographic impact of Kangyu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kangyu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kangyu Chen more than expected).

Fields of papers citing papers by Kangyu Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kangyu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kangyu Chen. The network helps show where Kangyu Chen may publish in the future.

Co-authorship network of co-authors of Kangyu Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Kangyu Chen. A scholar is included among the top collaborators of Kangyu Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kangyu Chen. Kangyu Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, R., Jingwen Li, Jing Zhu, et al.. (2025). Suppression of PCK1 attenuates neuronal injury and improves post-resuscitation outcomes. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(3). 167674–167674. 1 indexed citations
2.
Liang, Yongyi, et al.. (2025). Family strains, work passion drains: The impact of daily family demands on daily work passion. Journal of Business Research. 189. 115186–115186.
3.
4.
Wang, Qi, Guangchuan Wang, Jingjing Li, et al.. (2024). Characterizing Vericiguat Treatment in Heart Failure: A Multicenter Real-World Study in China. Reviews in Cardiovascular Medicine. 25(12). 427–427.
5.
Wang, Qi, et al.. (2024). Subclinical hypothyroidism: a new predictor of heart failure with improved ejection fraction in HFrEF patients. Internal and Emergency Medicine. 20(2). 481–488.
6.
Zhang, Zhuo, Zhiqiang Nie, Kangyu Chen, et al.. (2024). Association between intensive blood pressure lowering and stroke-free survival among patients with and without Diabetes. Scientific Reports. 14(1). 21551–21551. 1 indexed citations
7.
8.
Jiang, Zhixin, Fang Shao, Jingwen Hu, et al.. (2024). Time‐weighted blood pressure with cardiovascular risk among patients with or without diabetes. Clinical Cardiology. 47(1). e24213–e24213. 1 indexed citations
9.
Wang, Qi, Hao Su, Zhiquan Liu, et al.. (2023). Recurrent Heart Failure Hospitalizations in Heart Failure with Preserved Ejection Fraction: An Analysis of TOPCAT Trial. ESC Heart Failure. 11(1). 475–482. 1 indexed citations
10.
Chen, Kangyu, Zhenqiang Wu, Qi Wang, et al.. (2023). Longer time in blood pressure target range improves cardiovascular outcomes among patients with Type 2 diabetes: A secondary analysis of a randomized clinical trial. Diabetes Research and Clinical Practice. 198. 110600–110600. 6 indexed citations
11.
Chen, Kangyu, Chao Li, Victoria Cornelius, et al.. (2022). Prognostic Value of Time in Blood Pressure Target Range Among Patients With Heart Failure. JACC Heart Failure. 10(6). 369–379. 20 indexed citations
12.
Li, Chao, et al.. (2022). Hypertension Subtypes, Mortality Risk, and Differential Effects Between Two Hypertension Guidelines. Frontiers in Medicine. 9. 814215–814215. 4 indexed citations
13.
14.
Shen, Weiliang, Hongqi Li, Hao Su, Kangyu Chen, & Yan Ji. (2021). FTO overexpression inhibits apoptosis of hypoxia/reoxygenation-treated myocardial cells by regulating m6A modification of Mhrt. Molecular and Cellular Biochemistry. 476(5). 2171–2179. 66 indexed citations
15.
Wang, Qi, Bin Li, Kangyu Chen, et al.. (2021). Machine Learning-Based Risk Prediction of Malignant Arrhythmia in Hospitalized Patients with Heart Failure. ESC Heart Failure. 8(6). 5363–5371. 16 indexed citations
16.
Li, Chao, Kangyu Chen, Victoria Cornelius, et al.. (2021). Applicability and cost-effectiveness of the Systolic Blood Pressure Intervention Trial (SPRINT) in the Chinese population: A cost-effectiveness modeling study. PLoS Medicine. 18(3). e1003515–e1003515. 15 indexed citations
17.
Su, Hao, et al.. (2021). Carbonic anhydrase 2 and 3 as risk biomarkers for dilated cardiomyopathy associated heart failure. Annals of Palliative Medicine. 10(12). 12554–12565. 17 indexed citations
18.
19.
Su, Hao, et al.. (2018). Influence of the Right Ventricular Lead Location on Ventricular Arrhythmias in Cardiac Resynchronization Therapy. Chinese Medical Journal. 131(20). 2402–2409. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chandrashekhar K. Ponde Breakdown of academic impact, for papers by Anna Di Lorenzo Breakdown of academic impact, for papers by Xinchun Yang Breakdown of academic impact, for papers by Alessandra M. Campos‐Staffico Breakdown of academic impact, for papers by Cinzia Nugara Breakdown of academic impact, for papers by Matthew R. Deshotels Breakdown of academic impact, for papers by Hani Sabbour Breakdown of academic impact, for papers by Vincenzo Sucato Breakdown of academic impact, for papers by I Sathyamurthy Breakdown of academic impact, for papers by Tariq Ali Ahmad
Rankless by CCL
2026